NCT06453941

Brief Summary

The trial is designed to examine whether Yizhi Baduanjin could slow down and improve in memory, logical thinking and cerebral function in patients with mild cognitive impairment (MCI). 30 MCI patients will be recruited and randomly assigned to Yizhi Baduanjin intervention group control group for 6 months. The primary outcome is changes in Montreal Cognitive Assessment (MoCA) questionnaire; other outcome includes Cognitive Function Assessment questionnaire.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 10, 2023

Completed
21 days until next milestone

Study Start

First participant enrolled

May 1, 2023

Completed
1.1 years until next milestone

First Posted

Study publicly available on registry

June 12, 2024

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2025

Completed
Last Updated

June 17, 2025

Status Verified

June 1, 2025

Enrollment Period

1.8 years

First QC Date

April 10, 2023

Last Update Submit

June 12, 2025

Conditions

Keywords

Mild Cognitive Impairment (MCI)Alzheimers Disease (AD)Non-drug interventionBaduanjin

Outcome Measures

Primary Outcomes (1)

  • Changes in Montreal Cognitive Assessment (MoCA )

    Questionnaire with 8 categories, 33 items with a total score of 30.

    Baseline, 1-month, 3-month, 6-month

Secondary Outcomes (1)

  • Changes in Cognitive Function Assessment

    Baseline, 1-month, 3-month, 6-month

Study Arms (2)

Yizhi Baduanjin group

EXPERIMENTAL

The Yizhi Baduanjin group will practice Yizhi Baduanjin as intervention for 6 months, and the participants will be examined for assessment indicators on the 1st, 3rd, 6th month after the intervention started.

Other: Yizhi Baduanjin (Eight Pieces of Brocades for Mental Health Promotion)

Control group

NO INTERVENTION

The control group has no intervention until 6 months after the intervention of the experimental group started, but the participants will be examined for the same assessment indicators together with the experimental group.

Interventions

Yizhi Baduanjin (Eight Pieces of Brocades for Mental Health Promotion) is a newly compiled routine developed on the foundation of the traditional Baduanjin (Eight Pieces of Brocades), which is a traditional Chinese medical health exercise consisted of eight movements to be practiced by oneself.

Yizhi Baduanjin group

Eligibility Criteria

Age60 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • to 75 years old.
  • Voluntarily and sign the informed consent form.
  • Non-handicapped, able to complete the cognitive function examination.
  • Fulfill the diagnostic criteria.
  • Montreal Cognitive Assessment (MoCA )Scale \< 26

You may not qualify if:

  • Fail to comply to the requirements, or fail to complete the examination.
  • Unwilling or unable to learn and practice the Yizhi Baduanjin routine.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The University of Hong Kong

Hong Kong, 000000, Hong Kong

Location

MeSH Terms

Conditions

Cognitive DysfunctionAlzheimer Disease

Condition Hierarchy (Ancestors)

Cognition DisordersNeurocognitive DisordersMental DisordersDementiaBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesTauopathiesNeurodegenerative Diseases

Study Officials

  • Zhangjin Zhang, MMed, PhD

    The University of Hong Kong

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

April 10, 2023

First Posted

June 12, 2024

Study Start

May 1, 2023

Primary Completion

March 1, 2025

Study Completion

April 1, 2025

Last Updated

June 17, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will not share

Locations